Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19

S Forbes, M Davari… - Nephrology Dialysis …, 2021 - academic.oup.com
Background Haemodialysis (HD) patients are extremely vulnerable to coronavirus disease
2019 (COVID-19). Their immune response after infection is unclear. We have found high …

Hemodialysis patients with coronavirus disease 2019: reduced antibody response

H Beppu, T Fukuda, T Kawanishi, F Yasui… - Clinical and …, 2022 - Springer
Background Because patients on maintenance hemodialysis (HD) have an impaired
immune response to pathogens, they are at higher risk of severe coronavirus disease 2019 …

Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study

R Alcázar-Arroyo, J Portolés… - Clinical Kidney …, 2021 - academic.oup.com
Abstract Background Coronavirus disease 2019 (COVID-19) patients on haemodialysis
(HD) have high mortality. We investigated the value of reverse transcription polymerase …

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

M Toda, A Yoshifuji, K Kikuchi, M Koinuma… - Clinical and …, 2022 - Springer
Background The mortality rate of Coronavirus disease 2019 (COVID-19) is extremely high in
hemodialysis patients (HDP). These patients also develop lower antibody titers after …

COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection

I Boudhabhay, A Serris, A Servais… - Nephrology Dialysis …, 2022 - academic.oup.com
Background Patients on maintenance haemodialysis (HD) have an increased risk of severe
coronavirus disease 2019 (COVID-19) and a reduced response to vaccines. Data are …

Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose

A Angel-Korman, E Peres, G Bryk, Y Lustig… - Clinical Kidney …, 2022 - academic.oup.com
Background Humoral responses to coronavirus disease 2019 (COVID-19) vaccines in
hemodialysis (HD) patients can direct vaccination policy. Methods We compared 409 COVID …

Diminished short-and long-term antibody response after SARS-CoV-2 vaccination in hemodialysis patients

L Füessl, T Lau, I Lean, S Hasmann, B Riedl, FM Arend… - Vaccines, 2022 - mdpi.com
Short-term studies have shown an attenuated immune response in hemodialysis patients
after COVID-19-vaccination. The present study examines how antibody response is …

Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients

M Paal, FM Arend, T Lau, S Hasmann… - Clinical kidney …, 2021 - academic.oup.com
Background Some studies have shown an attenuated immune response in haemodialysis
patients after vaccination. The present study examines the humoral response after mRNA …

Antibody response to mRNA-1273 SARS-CoV-2 vaccine in hemodialysis patients with and without prior COVID-19

L Chan, N Fuca, E Zeldis, KN Campbell… - Clinical Journal of the …, 2021 - journals.lww.com
Patients on maintenance hemodialysis (HD) are highly susceptible to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1). Work by us and others …

IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis

C Dudreuilh, T Roper, C Breen, P Chowdhury… - Kidney international …, 2021 - kireports.org
Methods Guy's and St. Thomas' NHS Foundation Trust provide HD in two hospital-based
dialysis units and six satellite units for 697 patients currently. Patients who consented in July …